| Zacks Company Profile for STERIS plc (STE : NYSE) |  
					 
			    |  
		   
	  | 
|   | 
		  
					
					
						|   Company Description    |  
					
						| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
							 Number of Employees: 17,787  |  
					 
			    |  
		   
	  | 
|   | 
		  
					
					
						|   Price / Volume Information    |  
					
						| Yesterday's Closing Price: $235.70 | 
						Daily Weekly Monthly 
  |  
					
						| 20 Day Moving Average: 572,709 shares |  
					
						| Shares Outstanding: 98.49 (millions) |  
					
						| Market Capitalization: $23,214.24 (millions) |  
					
						| Beta: 1.02 |  
					
						| 52 Week High: $253.00 |  
					
						| 52 Week Low: $200.98 |  
					
						| Short Interest Ratio:  |  
					
						
							
							
										
										
											|   | 
											% Price Change | 
											% Price Change Relative to S&P 500 |  
										
											| 4 Week | 
											-2.80% | 
											-4.57% |  
										
											| 12 Week | 
											-2.94% | 
											-9.34% |  
										
											| Year To Date | 
											14.66% | 
											-1.41% |  
										 
								   |  
							 
						 |  
					 
				 |  
		   
	  | 
|   | 
| 
	  | 
|   | 
		  
					
					
						|   General Corporate Information    |  
					
						Officers 
							
							Daniel A. Carestio   - Chief Executive Officer; President and Director
										 Mohsen M. Sohi   - Chairman and Director
										 Michael J. Tokich   - Senior Vice President and Chief Financial Officer
										 Karen L. Burton   - Vice President and Chief Accounting Officer
										 Esther M. Alegria   - Director
										
								   |  
							 
						 | 
						Peer Information 
							
							STERIS plc (ABMD)
										 STERIS plc (DMDS)
										 STERIS plc (CPWY.)
										 STERIS plc (EQUR)
										 STERIS plc (ECIA)
										 STERIS plc (FMS)
								  |  
							 
						 |  
					
						Industry / Sector / Ticker Info 
							 
							 Analyst Coverage: No 
										Industry Group: MED INSTRUMENTS 
										Sector: Medical 
										CUSIP: G8473T100 
										SIC: 3842
								   |  
							  
						 | 
						Fiscal Year 
							 
							 Fiscal Year End: March 
										Last Reported Quarter: 06/01/25 
										Next Expected EPS Date: 11/05/25
								   |  
							  
						 |  
					
						Share - Related Items 
							 
							 Shares Outstanding: 98.49 
										Most Recent Split Date: 8.00 (2.00:1) 
										Beta: 1.02 
										Market Capitalization: $23,214.24 (millions)
								   |  
							  
						 | 
						  |  
					 
				 |  
		   
	  | 
|   | 
		  
					
					
						|   EPS Information    | 
						  Dividend Information |  
					
						| Analyst Coverage: No | 
						Dividend Yield: 1.07% |  
					
						| Current Fiscal Quarter EPS Consensus Estimate: $2.54 | 
						Indicated Annual Dividend: $2.52 |  
					
						| Current Fiscal Year EPS Consensus Estimate: $10.07 | 
						Payout Ratio: 0.24 |  
					
						| Number of Estimates in the Fiscal Year Consensus: 3.00 | 
						Change In Payout Ratio: 0.00 |  
					
						| Estmated Long-Term EPS Growth Rate: % | 
						Last Dividend Paid: 09/04/2025 - $0.63 |  
					
						| Next EPS Report Date: 11/05/25 | 
						  |  
					 
				 |  
		   
	  | 
|   |